However, the initial effect of BRAF inhibitors is usually not cytotoxic but cytostatic (i.e., G1 cell arrest) since the accumulation of pro-apoptotic BH3-only proteins is neutralized by the abundant amounts of anti-apoptotic proteins usually expressed by melanoma cells. The gene discussed is BRAF; the disease is melanoma.